Shopping Cart
- Remove All
- Your shopping cart is currently empty
JMS-17-2 hydrochloride, a highly potent and selective CX3CR1 antagonist with an IC 50 value of 0.32 nM, effectively impedes the metastatic seeding and colonization process of breast cancer cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $660 | 35 days | |
50 mg | $2,760 | 35 days |
Description | JMS-17-2 hydrochloride, a highly potent and selective CX3CR1 antagonist with an IC 50 value of 0.32 nM, effectively impedes the metastatic seeding and colonization process of breast cancer cells. |
Targets&IC50 | CX3CR1:0.32 nM (IC50) |
In vivo | JMS-17-2 (10 mg/kg; administered i.p.; twice a day for three weeks) significantly reduces tumor presence in the skeletal and visceral organs of SCID mice with MDA-231 xenografts[1], underscoring its effectiveness and demonstrating promise for further research into its anti-tumor capabilities. |
Molecular Weight | 456.41 |
Formula | C25H27Cl2N3O |
Cas No. | 2341841-07-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.